Baxter Net Income 2006-2018 | BAX

Baxter annual/quarterly net income history and growth rate from 2006 to 2018. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Baxter net income for the quarter ending September 30, 2018 was $0.544B, a 116.73% increase year-over-year.
  • Baxter net income for the twelve months ending September 30, 2018 was $1.205B, a 16.88% increase year-over-year.
  • Baxter annual net income for 2017 was $0.717B, a 85.56% decline from 2016.
  • Baxter annual net income for 2016 was $4.965B, a 412.91% increase from 2015.
  • Baxter annual net income for 2015 was $0.968B, a 61.23% decline from 2014.
Baxter Annual Net Income
(Millions of US $)
2017 $717
2016 $4,965
2015 $968
2014 $2,497
2013 $2,012
2012 $2,326
2011 $2,224
2010 $1,420
2009 $2,205
2008 $2,014
2007 $1,707
2006 $1,397
2005 $956
Baxter Quarterly Net Income
(Millions of US $)
Q3 2018 $544
Q2 2018 $343
Q1 2018 $389
Q4 2017 $-71
Q3 2017 $251
Q2 2017 $265
Q1 2017 $272
Q4 2016 $243
Q3 2016 $130
Q2 2016 $1,212
Q1 2016 $3,380
Q4 2015 $205
Q3 2015 $1
Q2 2015 $332
Q1 2015 $430
Q4 2014 $953
Q3 2014 $468
Q2 2014 $520
Q1 2014 $556
Q4 2013 $326
Q3 2013 $544
Q2 2013 $590
Q1 2013 $552
Q4 2012 $494
Q3 2012 $583
Q2 2012 $661
Q1 2012 $588
Q4 2011 $463
Q3 2011 $576
Q2 2011 $615
Q1 2011 $570
Q4 2010 $423
Q3 2010 $525
Q2 2010 $535
Q1 2010 $-63
Q4 2009 $572
Q3 2009 $530
Q2 2009 $587
Q1 2009 $516
Q4 2008 $569
Q3 2008 $472
Q2 2008 $544
Q1 2008 $429
Q4 2007 $478
Q3 2007 $395
Q2 2007 $431
Q1 2007 $403
Q4 2006 $432
Q3 2006 $374
Q2 2006 $309
Q1 2006 $282
Q4 2005 $292
Q3 2005 $116
Q2 2005 $322
Q1 2005 $226
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $33.541B $10.561B
Baxter International Inc., through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide. Baxter India is a wholly owned subsidiary of Baxter International Inc. Baxter India believes in engaging collaboratively with patients, healthcare providers, governments and non - government organizations to help change the lives of millions of people by providing safe, effective and affordable products and therapies.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $124.342B 19.06
Abbott Laboratories (ABT) United States $122.048B 24.73
Stryker (SYK) United States $62.796B 23.67
Boston Scientific (BSX) United States $50.730B 25.64
Zimmer Biomet Holdings (ZBH) United States $23.031B 14.94
Smith & Nephew SNATS (SNN) United Kingdom $16.007B 0.00
ResMed (RMD) United States $14.492B 27.64
Canopy Growth (CGC) Canada $8.934B 0.00
Perrigo (PRGO) Ireland $8.884B 13.48
Bio-Rad Laboratories (BIO) United States $8.054B 51.50
Aurora Cannabis (ACB) Canada $6.462B 35.26
Hill-Rom Holdings (HRC) United States $6.201B 19.66
Haemonetics (HAE) United States $5.495B 48.33
Insulet (PODD) United States $4.770B 0.00
ICU Medical (ICUI) United States $4.529B 25.23
Hutchison China MediTech (HCM) China $4.274B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.987B 0.00
Agios Pharmaceuticals (AGIO) United States $3.869B 0.00
Neogen (NEOG) United States $3.219B 48.74
National Vision Holdings (EYE) United States $3.101B 61.33
NuVasive (NUVA) United States $2.972B 27.65
Aphria (APHA) $2.572B 0.00
Quidel (QDEL) United States $2.478B 32.30
NxStage Medical (NXTM) United States $1.924B 0.00
Phibro Animal Health (PAHC) United States $1.476B 20.89
AtriCure (ATRC) United States $1.174B 0.00
Cardiovascular Systems (CSII) United States $1.015B 1462.50
VAREX IMAGING (VREX) United States $0.992B 19.93
Meridian Bioscience (VIVO) United States $0.827B 26.35
PetIQ (PETQ) United States $0.803B 22.83
OraSure Technologies (OSUR) United States $0.793B 44.65
Surmodics (SRDX) United States $0.776B 118.55
Eagle Pharmaceuticals (EGRX) United States $0.755B 24.22
Cerus (CERS) United States $0.719B 0.00
MacroGenics (MGNX) United States $0.710B 0.00
Omeros (OMER) United States $0.623B 0.00
Lantheus Holdings (LNTH) United States $0.590B 18.27
Owens & Minor (OMI) United States $0.558B 6.31
Insys Therapeutics (INSY) United States $0.542B 0.00
LeMaitre Vascular (LMAT) United States $0.518B 25.45
NanoString Technologies (NSTG) United States $0.481B 0.00
TG Therapeutics (TGTX) United States $0.438B 0.00
Evolus (EOLS) United States $0.399B 0.00
Quanterix (QTRX) United States $0.359B 0.00
Utah Medical Products (UTMD) United States $0.327B 21.12
Cytosorbents (CTSO) United States $0.302B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.255B 0.00
Surface Oncology (SURF) United States $0.226B 0.00
Rockwell Medical (RMTI) United States $0.211B 0.00
BioLife Solutions (BLFS) United States $0.206B 278.75
Bovie Medical (BVX) United States $0.201B 0.00
Chimerix (CMRX) United States $0.161B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.148B 0.00
Fonar (FONR) United States $0.139B 6.96
Chembio Diagnostics (CEMI) United States $0.104B 0.00
Imprimis Pharmaceuticals (IMMY) United States $0.081B 0.00
United-Guardian (UG) United States $0.079B 16.63
Female Health (VERU) United States $0.079B 0.00
Trinity Biotech (TRIB) Ireland $0.077B 24.40
Oramed Pharmaceuticals (ORMP) Israel $0.070B 0.00
InfuSystems Holdings (INFU) United States $0.067B 0.00
CAS Medical Systems (CASM) United States $0.056B 0.00
Neurotrope (NTRP) United States $0.050B 0.00
ImmuCell (ICCC) United States $0.041B 0.00
Capricor Therapeutics (CAPR) United States $0.028B 0.00
Myomo (MYO) United States $0.025B 0.00
Valeritas Holdings (VLRX) United States $0.021B 0.00
Senestech (SNES) United States $0.019B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.019B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
NeuroMetrix (NURO) United States $0.007B 0.00
Akers Biosciences Inc (AKER) United States $0.000B 0.00